Plasma leptin levels in rats with pancreatitis

Tohoku Journal of Experimental Medicine

Volumn 204, Issue 4, 2004, Pages 243-248

  Yavuz, Nihat ^c,d   Unal, Ethem ^a   Memisoglu, Kemal ^b   Krand, Osman ^a   Kiziler, Ali Riza ^c   Aydemir, Birsen ^c   Kusaslan, Ramazan ^c   Dogan, Mustafa ^c   Gunes, Pembegul ^a   Titiz, Izzet ^a  

^a Haydarpasa Numune Teaching and Research Hospital   (Turkey)

^b PTT Erenkoy Teaching Hospital   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

^d Caferaga Mah   (Turkey)

Author keywords

Acute pancreatitis; Chronic pancreatitis; Leptin

Indexed keywords

ALCOHOL; AMYLASE; LEPTIN; LEPTIN RECEPTOR; TRIACYLGLYCEROL LIPASE;

ACUTE PANCREATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CHRONIC PANCREATITIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; HISTOPATHOLOGY; LAPAROTOMY; MALE; NONHUMAN; PANCREAS FUNCTION; PANCREAS RESECTION; PROTEIN ANALYSIS; PROTEIN SYNTHESIS; RADIOIMMUNOASSAY; RAT;

ACUTE DISEASE; ANIMALS; CHRONIC DISEASE; HUMANS; LEPTIN; MALE; PANCREATITIS; RATS; RATS, WISTAR;

EID: 10244261470     PISSN: 00408727     EISSN: None     Source Type: Journal    
DOI: 10.1620/tjem.204.243     Document Type: Article

References (14)

1. Benomar, Y, Rideau, N., Crochet, S., Derouet, M. & Taouis, M. (2003) Leptin fully suppresses acetylcholine-induced insulin secretion and is reversed by tolbutamide in isolated perfused chicken pancreas. Horm. Metab. Res., 35, 81-85.
2. Caldefie-Chezet, F., Poulin, A., Tridon, A., Sion, B. & Vasson, M.P. (2001) Leptin: a potential regulator of polymorphonuclear neutrophil bactericidal action? J. Leukoc. Biol., 69, 414-418.
3. Committee on Care and Use of Laboratory Animals. (1985) Guide for the Care and Use of Laboratory Animals. Institute of Laboratory Animal Resources. National Research Council, Washington, D.C., 83.
4. Goren, I., Kampfer, H., Podda, M., Pfeilschifter, J. & Frank, S. (2003) Leptin and wound inflammation in diabetic ob/ob mice: differential regulation of neutrophil and macrophage influx and a potential role for the scab as a sink for inflammatory cells and mediators. Diabetes, 52, 2821-2832.
5. Jaworek, J., Bonior, J., Pierzchalski, P., Tomaszewska, R., Stachura, J., Sendur, R., Leja, A., Jachimczak, B., Konturek, P.C., Bielanski, W., Pawlik, W. & Konturek, S.J. (2002) Leptin protects the pancreas from damage induced by caerulein overstimulation by modulating cytokine production. Pancreatology, 2, 89-99.
6. Jaworek, J., Bonior, J., Konturek, S.J., Bilski, J., Szlachcic, A. & Pawlik, W.W. (2003) Role of leptin in the control of postprandial pancreatic enzyme secretion. J. Physiol. Pharmacol., 54, 591-602.
7. Konturek, P.C., Konturek, S.J., Brzozowski, T., Jaworek, J. & Hahn, E.G. (2001) Role of leptin in the stomach and the pancreas. J. Physiol. Paris, 95, 345-354.
8. Konturek, P.C., Jaworek, J., Maniatoglou, A., Bonior, J., Meixner, H., Konturek, S.J. & Hahn, E.G. (2002) Leptin modulates the inflammatory response in acute pancreatitis. Digestion, 65, 149-160.
9. Perez, C., Fernandez-Galaz, C., Fernandez-Agullo, T., Arribas, C., Andres, A., Ros, M. & Carrascosa, J.M. (2004) Leptin impairs insulin signaling in rat adipocytes. Diabetes, 53, 347-353.
10. Siegmund, B., Sennello, J.A., Jones-Carson, J., Gamboni-Robertson, F., Lehr, H.A., Batra, A., Fedke, I., Zeitz, M. & Fantuzzi, G. (2004) Leptin receptor expression on T lymphocytes modulates chronic intestinal inflammation in mice. Gut, 53, 965-972.
11. Seufert, J. (2004) Leptin effects on pancreatic beta-cell gene expression and function. Diabetes, 53, 152-158.
12. Warzecha, Z., Dembinski, A., Ceranowicz, P., Jaworek, J., Konturek, P.C., Dembinski, M., Bilskl, J. & Konturek, S.J. (2002) Influence of leptin administration on the course of acute ischemic pancreatitis. J. Physiol. Pharmacol., 53, 775-790.
13. Zarkesh-Esfahani, H., Pockley, A.G., Wu, Z., Hellewell, P.G., Weetman, A.P. & Ross, R.J. (2004) Leptin indirectly activates human neutrophils via induction of TNF-alpha. J. Immunol., 172, 1809-1814.
14. Zoccali, C., Mallamaci, F. & Tripepi, G. (2004) Inflammatory proteins as predictors of cardiovascular disease in patients with end-stage renal disease. Nephrol. Dial. Transplant., 19, 67-72.